In a recently released analyst research report, Bryan Garnier & Co.‘s Beverages and Cannabis Specialist Analyst, Nikolaas Faes, just initiated their buy rating on shares of Canadian licensed producer Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB) with a higher price target. Nikolaas Faes’s new price target of $16 CAD per share implies a potential upside of approximately 61% based…
You must be subscribed to PRO to view this content. To login, click here. To register, click here.
Get Real-Time Updates from The Daily Marijuana Observer